IRA
LIVE

Serial Number

88084340

Owner

Essenlix Corporation

Attorney

Xiongying Tu

First Use Date

Sep 1, 2022

Filing Date

Aug 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

IRA Trademark

Serial Number: 88084340 • Registration: 6885101

IRA is a trademark filed by Essenlix Corporation on August 20, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Essenlix Corporation (147 trademarks)

7 Foulet Dr
Princeton, CA 08540

Entity Type: 03

Trademark Details

Filing Date

August 20, 2018

Registration Date

October 25, 2022

First Use Anywhere

September 1, 2022

First Use in Commerce

September 1, 2022

Published for Opposition

July 23, 2019

Goods & Services

Medical diagnostic apparatus for testing cells, tissue, and biomolecules such as proteins, small molecules, cells, and nucleic acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, cancers, and abnormalities; Medical diagnostic testing apparatus, devices, and instruments for tests for personal wellness; Medical diagnostic testing apparatus, devices, and instruments for the detection and identification of nucleic acids such as DNA and RNA in a sample

Assays for research purposes; Nonmedical Biological and chemical reagents used for detecting and analyzing molecules in proteins or nucleotides, and in vitro and in vivo scientific use, and/or testing of bodily fluids; Assays for research purposes and biological and chemical reagents for scientific and research use used for tests for personal wellness; Assays for research purposes and biological and chemical reagents for scientific and research use used for the detection and identification of nucleic acids such as DNA and RNA in a sample

Reagents for medical use used for detecting and analyzing molecules in proteins or nucleotides, and in vitro and in vivo use, and/or testing of bodily fluids; reagents for medical use, used for test for personal wellness; reagents for medical use used for the detection and identification of nucleic acids such as DNA and RNA in a sample

Medical assistance; Medical consultations; Medical counseling; Medical information; Medical services; healthcare testing, diagnostic testing, and tests for personal wellness, namely, medical testing for diagnostic treatment purposes and fitness evaluation; Medical testing, namely, testing for the detection and identification of nucleic acids such as DNA and RNA in a sample

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 3, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 25, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 25, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 23, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 22, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 21, 2022 SUPC
USE AMENDMENT FILED
Sep 16, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 16, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2022 EXRA
SOU EXTENSION 5 GRANTED
Apr 1, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 24, 2022 AITU
SOU EXTENSION 5 FILED
Mar 17, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 17, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 21, 2021 EXRA
SOU EXTENSION 4 GRANTED
Sep 17, 2021 EX4G
SOU EXTENSION 4 FILED
Sep 17, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 17, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2021 EXRA
SOU EXTENSION 3 GRANTED
Mar 15, 2021 EX3G
SOU EXTENSION 3 FILED
Mar 15, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 15, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2020 EXRA
SOU EXTENSION 2 GRANTED
Sep 1, 2020 EX2G
SOU EXTENSION 2 FILED
Sep 1, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 1, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 29, 2020 EXRA
SOU EXTENSION 1 GRANTED
Feb 20, 2020 EX1G
SOU EXTENSION 1 FILED
Feb 20, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 20, 2020 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2020 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 17, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2019 CNEA
ASSIGNED TO EXAMINER
May 29, 2019 DOCK
ASSIGNED TO EXAMINER
May 29, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2019 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
May 20, 2019 CEPE
ASSIGNED TO LIE
May 20, 2019 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 20, 2019 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 20, 2019 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
May 20, 2019 CPEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2018 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2018 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2018 NWOS
NEW APPLICATION ENTERED
Aug 23, 2018 NWAP